Drug recall
Enrofloxacin+Ketoconazole+Triamcinolone, 0.5%/1%/0.1%, Otic in Pluronic in 30 mL syringes NDC 22200960806
FDA recall event 86015 · Class II · US Compounding Inc
Key facts
| Event ID | 86015 |
|---|---|
| Recall numbers | V-0465-2020 |
| Recalling firm | US Compounding Inc |
| Product type | Veterinary |
| Products | Enrofloxacin+Ketoconazole+Triamcinolone, 0.5%/1%/0.1%, Otic in Pluronic in 30 mL syringes NDC 22200960806 |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | cGMP deviations |
| Initiation date | Jul 1, 2020 |
| Report date | Jul 29, 2020 |
| Termination date | Nov 5, 2021 |
| City | Conway |
| State | AR |
| Country | United States |
| FEI number | 3006031801 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: